7.821.01% ( -0.08 )
Delay Closed: Nov 9, 15:00:00Current ValuationThe current P/E ratio is 13.65, within the reasonable range, cheaper than 67.48% of the time in the past 3 years, and the industry ranks 5/139, the industry Median 19.29.
13.65xP/E
¥7.82Stock price
¥0.57Earnings per share
13.65xP/E
Stock price¥7.82Earnings per share¥0.57
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 19.05x
- Typical range
- 8.68x–24.59x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 19.29x
011223344
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 19.29x
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
300972SZWanchen Group | 11.48x | 96.85% | ¥26.72B |
000833SZYUEGUI | 12.16x | -- | ¥14.55B |
000848SZLOLO | 13.03x | 8.20% | ¥8.05B |
600300SHVVFB | 14.57x | -- | ¥4.92B |
002582SZHAOXIANGNI | 2.19x | -- | ¥4.47B |
002772SZZhongxing BioTech | 13.65x | -- | ¥2.93B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
